Libros importados con hasta 50% OFF + Envío Gratis a todo USA  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Advances in Melanoma, an Issue of Hematology/Oncology Clinics: Volume 23-3 (in English)
Type
Physical Book
Publisher
Language
Inglés
Pages
240
Format
Hardcover
Dimensions
22.9 x 15.5 x 1.5 cm
Weight
0.50 kg.
ISBN
1437704883
ISBN13
9781437704884

Advances in Melanoma, an Issue of Hematology/Oncology Clinics: Volume 23-3 (in English)

David E. Fisher (Author) · Saunders · Hardcover

Advances in Melanoma, an Issue of Hematology/Oncology Clinics: Volume 23-3 (in English) - Fisher, David E.

Physical Book

$ 78.47

$ 130.79

You save: $ 52.31

40% discount
  • Condition: New
Origin: United Kingdom (Import costs included in the price)
It will be shipped from our warehouse between Tuesday, July 16 and Friday, July 26.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "Advances in Melanoma, an Issue of Hematology/Oncology Clinics: Volume 23-3 (in English)"

The field of melanoma biology has experienced a remarkable surge in recent years, owing to progress which has ranged from the most basic laboratory/preclinical discoveries to clinical developments that have begun to transform the management and prognosis for at least certain melanoma patients. Among the key areas that have contributed to this progress are studies relating to signaling and transcriptional pathways that regulate control over differentiation and survival of the melanocyte lineage. The identification of recurring activating mutations in specific signaling factors (B-RAF, N-Ras, c-KIT), amplification of other melanoma oncogenes (MITF, NEDD9), and the crucial recognition that certain of these genomic events occur within melanomas arising with specific clinical features (eg mucosal or acral origin) have led to clear recognition that melanoma is indeed "many different diseases." While the various subclasses of melanoma may share common features, such as profound invasive and metastatic propensity, it is also likely that sharply focused therapeutic strategies may exploit the functionally critical molecular engines, which distinguish these subclasses. Certain strategies focus upon the immunogenicity and striking clinical opportunities afforded by immune modulation, while others focus more directly on tumor-specific targeting. This issue brings together some of the leaders who have contributed significant insights from basic melanoma biology to progress in the clinic.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews